Your patent counsel needs to understand your technology. As a registered patent agent, Dan brings to his practice a detailed understanding of experimental science, focused expertise in a number of biotechnological disciplines and extensive, hands-on research experience.
He conducts nearly all aspects of practice before the United States Patent and Trademark Office, including patent prosecution, requests for reexamination, and appeals before the Patent Trial and Appeal Board. In addition, Dan advises on such matters as invalidity opinions, freedom to operate opinions, patentability opinions, licensing agreements, and litigation.
Dan has experience with a number of technologies, including enzymes, antibodies, medical devices, pharmaceutical compounds, cellular reprogramming methods, assays, assay platforms, nutraceutical compositions, disease treatments, nanopositioning systems, chemical manufacturing processes, and mechanical devices, among others.
His practice is informed with his expertise in a number of areas of bioscience, such as biochemistry, cell biology, molecular biology, microbiology, genetics, and genomics. He has researched molecular and cellular mechanisms underlying metabolic disease, particularly the role of certain protein receptors and enzymes in regulating lipid metabolism. He has also contributed to a genetic mapping of mRNA expression and metabolic profiles in an F2 intercross between diabetes-resistant and diabetes-susceptible mouse strains. In addition, he has conducted molecular genetic research on microbial pathogens and developed multiplex real-time PCR viral diagnostic arrays for the U.S. Department of Defense.
Dan works with university technology transfer organizations, individual inventors, and companies ranging from startups to multi-national corporations in securing their patent rights both domestically and internationally and in managing their patent portfolios.
“This is really brilliant…. You have won my business.” – CEO and founder of a biotechnology company, regarding a patent application directed to polymerase enzymes.
“I was amazed at how thorough a job you did. I could not really come up with any substantial additions to the information that we have talked about.” – Surgeon and inventor, regarding a patent application directed to a medical device.
“Kudos to the author of the main body. It is well written, so I have very few comments. Actually, I think we should talk about using it as the basis for a review article.” – University professor and inventor, regarding a patent application directed to genetically recombinant microorganisms.